December 23, PharmAust Commences MPL Manufacture for Human Clinical Trials
201223_PAA_Syngene_FightMND_Manufacture
December 22, PharmAust Set to Commence Phase IIb Anticancer Canine Trial
201222_PhaseIIbcaninetrial
December 21, Epichem Awarded DNDi Extension
201221_EpichemDNDi
December 4, Issued Capital
201204_IssuedCapital
2020 Annual Report
2020-Annual Report
November 30, Top 20 Shareholders
201130_Top_Holders_Report
November 5, AGM Results
201105_AnnualGeneralMeeting
October 31, Top 20 Shareholders
201031_Top_Holders_Report (87)
2020 Annual General Meeting Notice
201002_2020_Annual General Meeting
September 30, Top 20 Shareholders
Top_Holders_Report (84)